David is a results-driven life science professional skilled in business development and commercial strategy, technology commercialisation, company growth and transformation, and building and motivating teams.
Summary:
- A successful career in transforming and building value with life science and biotechnology SMEs
- Experienced as a CEO, director, senior manager and consultant with over 10 years Board level experience
- Proven team leader and motivator, excellent communication and interpersonal skills
- Entrepreneurial and dynamic but pragmatic and rational
- Considerable international experience from:
- extensive business development activities in Japan (50+ visits)
- 3 years living in USA
- 3 years as CEO of nanotechnology company in Belgium
Expertise and key skills:
Business development, commercial strategy and business planning, go to market strategy, company growth and transformation, sales management and planning, technology assessment, technology commercialisation and licensing, contracts and negotiation, team building and motivation.
Career Overview:
David has worked in the life science/biotech/pharmaceutical industry for over 30 years. After a first degree in Biochemistry and Doctorate in Computational Chemistry at the University of Oxford, he started his career as a scientist with Glaxo, before moving on to scientific management with drug discovery companies in the UK and then the USA.
In 1995 he transitioned into Business Development and initiated a drug discovery services group that he promoted globally, securing and directing long-term multi-$M contracts and collaborations with companies in the USA, Europe and Japan.
He continued his career heading Business Development teams then moved into consultancy, providing business development expertise and resource to a range of SMEs. In 2009 he undertook his first CEO role in Belgium, leading the transformation of the company, a move into a new market, securing new funding, and taking the first products to market.
Most recently he was CEO of a company manufacturing oligonucleotide reagents, where he turned around performance by driving transformation of the management team, increasing commercial activity, and implementing new structures and processes.
He was worked in a range of markets including: molecular diagnostics, genomics, bioinformatics, small molecule and antibody discovery, nanotechnology, stem-cells, and affinity reagents.
David has also experienced and successfully worked through many challenging commercial scenarios, including technology restrictions, finance limitations and personnel issues.
Recent posts:
2017 – present: Independent Consultant
2014 – 2016: CEO, Link Technologies
2012 – 2014: Interim CEO, FibromEd
2009 – 2012: CEO, PharmaDiagnostics NV
2004 – 2014: Independent Consultant
2003 – 2004: Director of Business Development, Maybridge
2000 – 2003: VP Business Development, Inpharmatica
If you would like to speak to David you can contact andrew.burns@georgejamesltd.com
Free services supported by paid for services. If you or any of your contacts are considering engaging a recruiter, consultant or trainer we will welcome the opportunity to be considered.